Clinical Trial Update: Investigating Clinical Efficacy of Ofatumumab in Adult Rheumatoid Arthritis (RA) Patients Who Had an Inadequate Response to MTX Therapy [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating ofatumumab in adults with rheumatoid arthritis who had an inadequate response to methotrexate was terminated, with results posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Arzerra (ofatumumab)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Arthritis, Rheumatoid | Phase 3 | Status: TERMINATED | Results posted: 2011-10-28